Extended Data Table 1.
Fenethylline binding to CNS targets.
| Target | Inhib. (%)* | Target | Inhib. (%)* |
|---|---|---|---|
| AdenosineA2A | −5 | Muscarinic M2 | −6 |
| Adenosine A1 | 0 | Muscarinic M3 | 2 |
| Adrenergic α2A | 16 | Nicotinic Ach | 2 |
| Adrenergic α1A | 27 | Nicotinic Ach α1 | 9 |
| Adrenergic α1B | 16 | Mu Opiate | 7 |
| Adrenergic β2 | 3 | Phorbol Ester | 9 |
| Adrenergic β1 | 9 | K ATP Channel | 21 |
| L-Type Ca Channel | 6 | hERG K Channel | −4 |
| Cannabinoid CB1 | 16 | Prostanoid EP4 | 3 |
| Dopamine D2S | 1 | Rolipram | 9 |
| Dopamine D1 | 8 | Serotonin 5-HT2B | 23 |
| GABAA – Site 1 | 0 | Sigma σ1 | 7 |
| GABAA – Site 2 | 5 | Na Channel – Site 2 | −4 |
| Glutamate – NMDA | 10 | Norepi. Transporter | 10 |
| Histamine H1 | 12 | Dop. Transporter | 9 |
| Imidazoline I2 | 4 |
Radioligand displacement measured in the presence of 10 μM fenethylline using the method of Eurofins Cerep Panlabs. Data shown as the average of two replicates.